Literature DB >> 22361360

Disparity in infection control practices for multidrug-resistant Enterobacteriaceae.

Christopher Lowe1, Kevin Katz, Allison McGeer, Matthew P Muller.   

Abstract

BACKGROUND: There is a lack of empiric evidence regarding the optimal approach to controlling the transmission of extended-spectrum β-lactamase-producing Enterobacteriaceae (ESBL-E) and carbapenem-resistant Enterobacteriaceae (CRE). In this context, we expect that infection control practices for these organisms vary widely between hospitals.
METHODS: A survey examining infection control practices for ESBL-E and CRE was distributed to 6 academic and 9 community hospitals in Toronto, Canada.
RESULTS: All hospitals responded to the survey. Among 15 hospitals in 1 geographic area, 8 different approaches to the management of ESBL-E were utilized. There was wide variation in the use infection control practices including admission screening (53% and 53%), contact precautions (53% and 100%), and isolation (60% and 100%) for ESBL-E and CRE, respectively. Of hospitals performing admission screening, 75% used risk factor-based screening for ESBL-E and CRE.
CONCLUSION: Even within a single geographic area, there is wide variation in infection control strategies to contain or control ESBL-E and CRE. These results are concerning given evidence that a coordinated approach may be required to prevent or limit the emergence of CRE.
Copyright © 2012 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22361360     DOI: 10.1016/j.ajic.2011.11.008

Source DB:  PubMed          Journal:  Am J Infect Control        ISSN: 0196-6553            Impact factor:   2.918


  9 in total

1.  Characteristics and management of Enterobacteriaceae harboring IMP-4 or IMP-8 carbapenemase in a tertiary hospital.

Authors:  Feng Pang; Xiu-Qin Jia; Zhen-Zhu Song; Yan-Hua Li; Bin Wang; Qi-Gang Zhao; Chuan-Xin Wang; Yi Zhang; Le-Xin Wang
Journal:  Afr Health Sci       Date:  2016-03       Impact factor: 0.927

2.  Decreased susceptibility to noncarbapenem antimicrobials in extended-spectrum-β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Toronto, Canada.

Authors:  Christopher F Lowe; Allison McGeer; Matthew P Muller; Kevin Katz
Journal:  Antimicrob Agents Chemother       Date:  2012-04-16       Impact factor: 5.191

Review 3.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

Review 4.  NDM Metallo-β-Lactamases and Their Bacterial Producers in Health Care Settings.

Authors:  Wenjing Wu; Yu Feng; Guangmin Tang; Fu Qiao; Alan McNally; Zhiyong Zong
Journal:  Clin Microbiol Rev       Date:  2019-01-30       Impact factor: 26.132

5.  Targeted screening for third-generation cephalosporin-resistant Enterobacteriaceae carriage among patients admitted to intensive care units: a quasi-experimental study.

Authors:  Cédric Dananché; Thomas Bénet; Bernard Allaouchiche; Romain Hernu; Laurent Argaud; Olivier Dauwalder; François Vandenesch; Philippe Vanhems
Journal:  Crit Care       Date:  2015-02-10       Impact factor: 9.097

6.  Screening and contact precautions - A survey on infection control measures for multidrug-resistant bacteria in German university hospitals.

Authors:  Lena M Biehl; Hartmut Bertz; Johannes Bogner; Ute-Helke Dobermann; Johanna Kessel; Carolin Krämer; Sebastian Lemmen; Marie von Lilienfeld-Toal; Silke Peter; Mathias W Pletz; Holger Rohde; Stefan Schmiedel; Sören Schubert; Andrew J Ullmann; Gerd Fätkenheuer; Maria J G T Vehreschild
Journal:  Antimicrob Resist Infect Control       Date:  2017-04-13       Impact factor: 4.887

7.  Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.

Authors:  Feng Pang; Xiu-Qin Jia; Qi-Gang Zhao; Yi Zhang
Journal:  Ann Clin Microbiol Antimicrob       Date:  2018-03-23       Impact factor: 3.944

8.  Efficacy of admission screening for extended-spectrum beta-lactamase producing Enterobacteriaceae.

Authors:  Christopher F Lowe; Kevin Katz; Allison J McGeer; Matthew P Muller
Journal:  PLoS One       Date:  2013-04-26       Impact factor: 3.240

9.  Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.

Authors:  Matthieu Domenech de Cellès; Jean-Ralph Zahar; Véronique Abadie; Didier Guillemot
Journal:  BMC Infect Dis       Date:  2013-04-24       Impact factor: 3.090

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.